In my earlier blogpost I mentioned Cyclodextrin being able to dissolve cholesterol and help the body remove plaque. Since cardiovascular disease causes 1/3 of deaths worldwide, does it not make sense to do something about this with some of our digital token based wealth?
"What cyclodextrin did was to reprogram the macrophage so it didn't create such a big inflammatory response," Espevik said. That meant the macrophage could soak up excess cholesterol and remove it, while reducing the inflammation in the artery walls and thus reducing the likelihood of causing a plaque to form.
Latz estimates it will take approximately EUR 1 million to do the trials. One potential drawback is also one of the most positive aspects of cyclodextrin: the substance, which is a type of sugar, has already been approved by the US Food and Drug Administration for use in humans. But because it has been in existence for some time, it cannot be patented. That makes it harder to get a drug company interested in developing cyclodextrin to treat heart disease, but it also will make it easier to get the drug approved to treat heart disease if the clinic trials support the research findings.
An ICO can be launched on Ethereum or EOS to fund the random control trial for Cyclodextrin and to produce a supplement. A subscription model can be used to pre-sell the supplement and the money from sales can be used to buyback the token held by token holders who contributed to the presale.
Thoughts?